<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Choroidal Neovascularization - Abnormal Blood Vessels Guide | Vision Health Portal</title>
    <meta name="description"
        content="Comprehensive guide to choroidal neovascularization (CNV): abnormal new blood vessels growing from choroid into retina, most common in wet AMD, causes bleeding and distortion, anti-VEGF injections highly effective treatment.">
    <link rel="stylesheet" href="../style.css">
    <link rel="stylesheet" href="disease-style.css">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.0.0/css/all.min.css">
</head>

<body>
    <header>
        <a href="../index.html" class="logo">
            <i class="fas fa-eye"></i> VisionHealth
        </a>
        <nav>
            <ul>
                <li><a href="../index.html">Home</a></li>
                <li><a href="../tests/index.html">Vision Tests</a></li>
                <li><a href="../innovations.html">Innovations</a></li>
            </ul>
        </nav>
    </header>

    <div class="disease-hero">
        <h1>Choroidal Neovascularization</h1>
        <p>Abnormal Blood Vessels Under the Retina</p>
        <span class="category"><i class="fas fa-tag"></i> Retinal Vascular Disorder</span>
    </div>

    <div class="disease-content-wrapper">
        <aside class="toc">
            <h3>Contents</h3>
            <ul>
                <li><a href="#overview">Overview</a></li>
                <li><a href="#causes">Causes</a></li>
                <li><a href="#symptoms">Symptoms</a></li>
                <li><a href="#diagnosis">Diagnosis</a></li>
                <li><a href="#treatment">Treatment</a></li>
                <li><a href="#prognosis">Prognosis</a></li>
                <li><a href="#when-to-see">When to See a Doctor</a></li>
            </ul>
        </aside>

        <main class="disease-content">
            <section id="overview">
                <h2>What Is Choroidal Neovascularization?</h2>
                <p>Choroidal neovascularization (CNV), also called a choroidal neovascular membrane, is the growth of
                    abnormal new blood vessels from the choroid (the vascular layer beneath the retina) through Bruch's
                    membrane into the subretinal space or retina. These abnormal vessels are fragile and leaky, causing
                    fluid accumulation, bleeding, and scarring under and within the retina, leading to distorted and
                    decreased central vision. CNV is not a disease itself but a complication of several retinal
                    conditions, most commonly wet (exudative/neovascular) age-related macular degeneration (AMD).</p>

                <p>In wet AMD CNV develops in response to chronic retinal ischemia and damage, driven by vascular
                    endothelial growth factor (VEGF). Other causes include pathologic myopia (high nearsightedness),
                    ocular histoplasmosis syndrome, trauma, and inflammatory conditions. Symptoms include sudden or
                    gradual central vision loss, metamorphopsia (straight lines appearing wavy/distorted), and central
                    scotoma (blind spot). Diagnosis is made using OCT (showing fluid/bleeding) and fluorescein
                    angiography (showing leaking vessels). Treatment with anti-VEGF injections (Eylea, Lucentis,
                    Avastin) is highly effective, stabilizing or improving vision in most patients by blocking VEGF and
                    causing CNV regression.</p>

                <div class="key-facts">
                    <h3><i class="fas fa-info-circle"></i> Key Facts About Choroidal Neovascularization</h3>
                    <ul>
                        <li><strong>Abnormal vessels from choroid grow into retina/subretinal space</strong></li>
                        <li><strong>Fragile, leaky vessels cause fluid, bleeding, scarring</strong></li>
                        <li><strong>Most common cause: wet AMD</strong></li>
                        <li><strong>Other causes: pathologic myopia, histoplasmosis, trauma</strong></li>
                        <li><strong>Symptoms: distortion (metamorphopsia), central vision loss</strong></li>
                        <li><strong>Diagnosis: OCT, fluorescein angiography</strong></li>
                        <li><strong>Treatment: anti-VEGF injections</strong> (Eylea, Lucentis, Avastin)—highly
                            effective.</li>
                        <li><strong>Requires ongoing treatment</strong> to maintain vision.</li>
                    </ul>
                </div>

                <p>Understanding CNV emphasizes the importance of prompt treatment with anti-VEGF to preserve central
                    vision.</p>
            </section>

            <section id="causes">
                <h2>Causes of Choroidal Neovascularization</h2>

                <h3>Wet Age-Related Macular Degeneration (AMD) - Most Common</h3>
                <ul>
                    <li>~80-90% of CNV cases</li>
                    <li>Chronic damage to retinal pigment epithelium (RPE) and Bruch's membrane → CNV develops</li>
                    <li>Affects people >50-60 years</li>
                </ul>

                <h3>Pathologic Myopia (High Nearsightedness)</h3>
                <ul>
                    <li>Second most common cause in younger patients</li>
                    <li>Elongated eyeball → retinal/choroidal stretching, breaks in Bruch's membrane → CNV</li>
                </ul>

                <h3>Ocular Histoplasmosis Syndrome</h3>
                <ul>
                    <li>Fungal infection (Histoplasma capsulatum) causes choroidal scars ("histo spots")</li>
                    <li>Scars can develop CNV years later</li>
                    <li>More common in certain geographic regions (Ohio/Mississippi River valleys)</li>
                </ul>

                <h3>Angioid Streaks</h3>
                <ul>
                    <li>Breaks in Bruch's membrane from various causes (pseudoxanthoma elasticum, Paget's disease,
                        sickle cell, trauma)</li>
                    <li>CNV can develop at streaks</li>
                </ul>

                <h3>Trauma</h3>
                <ul>
                    <li>Blunt eye injury → choroidal rupture → CNV</li>
                </ul>

                <h3>Inflammatory Conditions</h3>
                <ul>
                    <li>Posterior uveitis, multifocal choroiditis</li>
                </ul>

                <h3>Idiopathic (Unknown Cause)</h3>
                <ul>
                    <li>Some cases no clear underlying condition</li>
                </ul>
            </section>

            <section id="symptoms">
                <h2>Recognizing the Symptoms</h2>

                <div class="symptoms-grid">
                    <div class="symptom-card">
                        <h4><i class="fas fa-wave-square"></i> Metamorphopsia (Distortion)</h4>
                        <p>Straight lines appear wavy, bent, or irregular (e.g., door frames, window blinds); hallmark
                            symptom; detected by Amsler grid.</p>
                    </div>

                    <div class="symptom-card">
                        <h4><i class="fas fa-cloud"></i> Blurred Central Vision</h4>
                        <p>Difficulty reading, recognizing faces; central vision affected.</p>
                    </div>

                    <div class="symptom-card">
                        <h4><i class="fas fa-circle-notch"></i> Central Scotoma (Blind Spot)</h4>
                        <p>Dark or blurry spot in center of vision.</p>
                    </div>

                    <div class="symptom-card">
                        <h4><i class="fas fa-tachometer-alt"></i> Rapid or Gradual Onset</h4>
                        <p>Can be sudden (from bleeding) or gradual (fluid accumulation).</p>
                    </div>

                    <div class="symptom-card">
                        <h4><i class="fas fa-adjust"></i> Decreased Contrast Sensitivity</h4>
                        <p>Colors seem washed out, dim.</p>
                    </div>

                    <div class="symptom-card">
                        <h4><i class="fas fa-ban"></i> Painless</h4>
                        <p>No pain.</p>
                    </div>
                </div>

                <h3>Amsler Grid Test</h3>
                <ul>
                    <li>Grid of straight lines</li>
                    <li>CNV causes lines to appear wavy or distorted</li>
                    <li>Useful for home monitoring</li>
                </ul>
            </section>

            <section id="diagnosis">
                <h2>Diagnosis</h2>

                <h3>Dilated Fundus Examination</h3>
                <ul>
                    <li>May see grayish-green subretinal membrane, hemorrhage, fluid, lipid exudates</li>
                </ul>

                <h3>Optical Coherence Tomography (OCT) - Key Test</h3>
                <ul>
                    <li>Cross-sectional retinal imaging</li>
                    <li><strong>Shows:</strong>
                        <ul>
                            <li>Subretinal or intraretinal fluid</li>
                            <li>CNV as hyperreflective material under retina</li>
                            <li>Retinal thickening</li>
                        </ul>
                    </li>
                    <li>Guides treatment, monitors response</li>
                    <li><strong>OCT angiography (OCTA):</strong> Non-invasive imaging of CNV blood flow</li>
                </ul>

                <h3>Fluorescein Angiography (FA)</h3>
                <ul>
                    <li>Dye injected IV; retinal photographs taken</li>
                    <li><strong>Shows:</strong> CNV as area of hyperfluorescence (bright leakage) from leaking vessels
                        <ul>
                            <li>Classic CNV: well-defined</li>
                            <li>Occult CNV: poorly defined</li>
                        </ul>
                    </li>
                    <li>Confirms diagnosis, characterizes CNV</li>
                </ul>

                <h3>Indocyanine Green Angiography (ICGA)</h3>
                <ul>
                    <li>Alternative dye; better for visualizing choroidal vessels</li>
                    <li>Used if FA unclear</li>
                </ul>
            </section>

            <section id="treatment">
                <h2>Treatment</h2>

                <h3>Anti-VEGF Injections - First-Line, Highly Effective</h3>
                <ul>
                    <li><strong>Medications:</strong> Aflibercept (Eylea), ranibizumab (Lucentis), bevacizumab (Avastin,
                        off-label)</li>
                    <li><strong>Mechanism:</strong> Block vascular endothelial growth factor (VEGF) → CNV vessels
                        regress, fluid/bleeding resolves</li>
                    <li><strong>Procedure:</strong> Intravitreal injection (into vitreous gel) in office
                        <ul>
                            <li>Topical anesthesia, very quick procedure</li>
                        </ul>
                    </li>
                    <li><strong>Schedule:</strong>
                        <ul>
                            <li>Loading phase: Monthly injections × 3-4 months initially</li>
                            <li>Maintenance: As-needed (PRN) based on OCT, or fixed interval (every 6-12 weeks), or
                                treat-and-extend protocol</li>
                            <li>Ongoing treatment needed; CNV can recur if treatment stopped</li>
                        </ul>
                    </li>
                    <li><strong>Effectiveness:</strong> ~90% stabilize vision, ~30-40% improve vision significantly</li>
                    <li>Revolutionized CNV treatment</li>
                </ul>

                <h3>Photodynamic Therapy (PDT) - Less Common Now</h3>
                <ul>
                    <li>Verteporfin (Visudyne) dye injected IV, activated by laser to CNV area</li>
                    <li>Causes selective CNV closure</li>
                    <li>Largely replaced by anti-VEGF (more effective, fewer side effects)</li>
                    <li>Sometimes used in combination with anti-VEGF for certain CNV types</li>
                </ul>

                <h3>Laser Photocoagulation (Thermal Laser) - Rarely Used Now</h3>
                <ul>
                    <li>Destroys CNV with laser</li>
                    <li>Creates permanent retinal scar → vision loss at laser site</li>
                    <li>Only for peripheral CNV (not involving fovea)</li>
                    <li>Mostly historical; anti-VEGF preferred</li>
                </ul>

                <h3>Low Vision Aids (If Advanced)</h3>
                <ul>
                    <li>Magnifiers, high-contrast materials if vision severely impaired despite treatment</li>
                </ul>
            </section>

            <section id="prognosis">
                <h2>Prognosis and Outcomes</h2>

                <h3>With Anti-VEGF Treatment</h3>
                <ul>
                    <li><strong>Vision stabilization:</strong> ~90% maintain or improve vision</li>
                    <li><strong>Vision improvement:</strong> ~30-40% gain significant vision (≥3 lines on chart)</li>
                    <li>Earlier treatment → better outcomes</li>
                    <li>Ongoing injections needed (can be lifelong)</li>
                </ul>

                <h3>Without Treatment</h3>
                <ul>
                    <li>Progressive vision loss</li>
                    <li>CNV leads to scarring (disciform scar) → permanent central vision loss</li>
                </ul>

                <h3>Recurrence</h3>
                <ul>
                    <li>CNV can reactivate if treatment stopped</li>
                    <li>Regular monitoring (OCT) essential</li>
                </ul>
            </section>

            <section id="when-to-see">
                <h2>When to See a Doctor</h2>

                <h3>See Eye Doctor Urgently (Within Days) If:</h3>
                <ul>
                    <li><strong>Straight lines appear wavy or distorted</strong></li>
                    <li><strong>Sudden or gradual central vision loss or blur</strong></li>
                    <li><strong>Central blind spot</strong></li>
                    <li><strong>Any change in vision if you have AMD, pathologic myopia, or other risk factors</strong>
                    </li>
                </ul>

                <h3>Home Monitoring</h3>
                <ul>
                    <li><strong>Amsler grid:</strong> Check daily (if AMD or at risk)
                        <ul>
                            <li>Cover one eye, look at center dot</li>
                            <li>If lines wavy/distorted → see doctor immediately</li>
                        </ul>
                    </li>
                </ul>

                <h3>Questions to Ask Your Doctor</h3>
                <ul>
                    <li>Do I have choroidal neovascularization?</li>
                    <li>What caused it?</li>
                    <li>Do I need anti-VEGF injections?</li>
                    <li>How often will I need injections?</li>
                    <li>What is my prognosis for vision?</li>
                    <li>Should I monitor at home with Amsler grid?</li>
                </ul>
            </section>

            <div class="alert-box info">
                <h4><i class="fas fa-lightbulb"></i> Bottom Line</h4>
                <p>Choroidal neovascularization (CNV) is the growth of abnormal, fragile, leaky blood vessels from the
                    choroid into the retina, causing fluid accumulation, bleeding, distortion, and central vision loss.
                    It's most commonly a complication of wet age-related macular degeneration (AMD), but also occurs in
                    pathologic myopia, ocular histoplasmosis, trauma, and other conditions. The hallmark symptom is
                    metamorphopsia—straight lines appearing wavy—best detected with an Amsler grid. Diagnosis is made
                    with OCT (showing fluid/CNV) and fluorescein angiography (showing leaking vessels). Treatment with
                    anti-VEGF injections (Eylea, Lucentis, Avastin) into the eye is highly effective, stabilizing vision
                    in ~90% and improving it in ~30-40% by blocking VEGF and causing CNV regression. Ongoing injections
                    are needed to maintain results. Without treatment, CNV leads to progressive scarring and permanent
                    central vision loss. If you notice distortion or central vision changes, see a retina specialist
                    urgently—early treatment with anti-VEGF offers the best chance of preserving vision.</p>
            </div>

            <div class="related-diseases">
                <h3>Related Eye Conditions</h3>
                <div class="related-links">
                    <a href="macular-degeneration.html">Macular Degeneration</a>
                    <a href="myopia.html">Myopia</a>
                    <a href="diabetic-retinopathy.html">Diabetic Retinopathy</a>
                </div>
            </div>
        </main>
    </div>

    <footer>
        <div class="footer-content">
            <p>&copy; 2025 Vision Health Portal. All rights reserved.</p>
            <p class="designer-credit">Designed by RITIK DHAGE</p>
            <p style="font-size: 0.85rem; margin-top: 1rem; opacity: 0.8;">
                <i class="fas fa-info-circle"></i> This information is for educational purposes only and is not a
                substitute for professional medical advice, diagnosis, or treatment.
            </p>
        </div>
    </footer>
</body>

</html>